PropertyValue
?:abstract
  • The biological anakinra appears promising to halt cytokine storm syndrome seen in severe courses of COVID‐19. However, immunosuppression with anakinra may facilitate sepsis, necessitating continuous screening for bacterial superinfections.
is ?:annotates of
?:creator
?:doi
  • 10.1002/ccr3.3307
?:doi
?:journal
  • Clin_Case_Rep
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/8c81d6877c2dd8c05dd6224a1f5cd504606fd15d.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7752410.xml.json
?:pmcid
?:pmid
?:pmid
  • 33363865.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
?:type
?:year
  • 2020-09-15

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/l15jc345>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/l15jc345>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all